FDA is warning consumers not to purchase and immediately stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination.
OTI opened with a pilot program to provide services to patients as well as clinical experience to graduate students in the Department of Occupational Therapy. The pilot program was successful; however, we do not have the funding needed to move to the next stage.
If you have questions or comments, please use the form below.